The origin of genetic risk for nasopharyngeal carcinoma: A commentary on is nasopharyngeal cancer really a "Cantonese cancer"?

Chinese Journal of Cancer

Volumn 29, Issue 5, 2010, Pages 527-537

  Simons, Malcolm J ^a  

^a Simons Haplomics Limited   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; NITROSAMINE; VIRUS DNA;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ETHNICITY; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; NASOPHARYNX CARCINOMA; NONHUMAN; POPULATION DISTRIBUTION;

EID: 79954536329     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10070     Document Type: Article

References (117)

1. Li CC, Yu MC, Henderson BE. Some epidemiologic observations of nasopharyngeal carcinoma in Guangdong, People's Republic of China [J]. Natl Cancer Inst Monogr, 1985, 69: 49-52.
2. Kumar S, Mahanta J. Aetiology of nasopharyngeal carcinoma. A review [J]. Indian J Cancer, 1998, 35(2): 47-56.
3. Devi BC, Pisani P, Tang TS, Parkin DM. High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island [J]. Cancer Epidemiol Biomarkers Prev, 2004, 13(3): 482-486.
4. Wang CJ, Lin FJ, Leung W, et al. Occurrence of nasopharyngeal carcinoma in aboriginals of Taiwan: report of 14 cases [J]. J Formos Med Assoc, 1992, 91(11): 1044-1048.
5. Ko YC, Liu BH, Hsieh SF, et al. Cancer mortality analysis among aborigines in Taiwan [J]. Gaoxiong Yi Xue Ke Xue Za Zhi, 1994, 10(7): 379-391. [in Chinese]
6. Nielsen NH, Mikkelsen F, Hansen JP. Nasopharyngeal cancer in Greenland. The incidence in an Arctic Eskimo population [J]. Acta Pathol Microbiol Scand A, 1977, 85(6): 850-858.
7. de-Thé G, Ambrosioni JC, Ho HC, et al. Lymphoblastoid transformation and presence of herpes-type viral particles in a Chinese nasopharyngeal tumour cultured in vitro [J]. Nature, 1969, 221(5182): 770-771.
8. Zur Hausen H, Schulte-Holthausen H, Klein G, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx [J]. Nature, 1970, 228(5276): 1056-1058.
9. Liebowitz D. Nasopharyngeal carcinoma: the Epstein-Barr virus association [J]. Semin Oncol, 1994, 21(3): 376-381.
10. Takada K, Shimizu N, Tanabe-Tochikura A, et al. Pathogenic role of Epstein-Barr virus in human cancer [J]. Intervirology, 1995, 38(3-4): 214-220.
11. Pagano JS. Epstein-Barr virus: the first human tumor virus and its role in cancer [J]. Proc Assoc Am Physicians, 1999, 111(6): 573-580.
12. Hsu JL, Glaser SL. Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications [J]. Crit Rev Oncol Hematol, 2000, 34(1): 27-53.
13. Dolcetti R, Menezes J. Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: new immunobiological and molecular insights on a long-standing etiopathogenic association [J]. Adv Cancer Res, 2003, 87: 127-157.
14. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours [J]. Oncogene, 2003, 22(33): 5108-5121.
15. Chou J, Lin YC, Kim J, et al. Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis [J]. Head Neck, 2008, 30(7): 946-963.
16. Niller HH, Wolf H, Minarovits J. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia [J]. Semin Cancer Biol, 2009, 19(3): 158-164.
17. Shah KM, Young LS. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma [J]. Clin Microbiol Infect, 2009, 15(11): 982-988.
18. Maeda E, Akahane M, Kiryu S, et al. Spectrum of Epstein-Barr virus-related diseases: a pictorial review [J]. Jpn J Radiol, 2009, 27(1): 4-19.
19. Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation [J]. Semin Cancer Biol, 2004, 14(6): 453-471.
20. de Martel C, Franceschi S. Infections and cancer: established associations and new hypotheses [J]. Crit Rev Oncol Hematol, 2009, 70(3): 183-194.
21. Simons MJ, Wee GB, Chan SH, et al. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-A type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC [J]. IARC Sci Publ, 1975, (11 Pt 2): 249-258.
22. Simons MJ. Immunogenetic-immunovirologic strategy in human cancer research: application to carcinomas of the nasopharynx and liver [D], Tokyo, Japan: University of Tokyo, 1975.
23. Simons MJ, Chan SH, Ou BX. Nasopharyngeal Carcinoma (NPC), including analysis of HLA gene patterns in Chinese patients with Cervical and Hepatocellular Carcinoma [M]. Simons MJ, Tait BD, eds. Proceeding of the Second Asia and Oceania Histocompatibility Workshop Conference: Immunopublishing, Publishing Division of Immunosearch Unit Trust, 445 Toorak Road, Toorak, 3142, Victoria, Australia (ISBN 0 9591744 0 0), 1983: 369-378.
24. Ho JH, Huang DP, Fong YY. Salted fish and nasopharyngeal carcinoma in southern Chinese [J]. Lancet, 1978, 2(8090): 626.
25. Fong LY, Ho JH, Huang DP. Preserved foods as possible cancer hazards: WA rats fed salted fish have mutagenic urine [J]. Int J Cancer, 1979, 23(4): 542-546.
26. Yu MC, Ho JH, Lai SH, et al. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong [J]. Cancer Res, 1986, 46(2): 956-961.
27. Fong YY, Walsh EO. Carcinogenic nitrosamines in Cantonese salt-dried fish [J]. Lancet, 1971, 2(7732): 1032.
28. Mirvish SS. N-nitroso compounds: their chemical and in vivo formation and possible importance as environmental carcinogens [J]. J Toxicol Environ Health, 1977, 2(6): 1267-1277.
29. Zou XN, Lu SH, Liu B. Volatile N-nitrosamines and their precursors in Chinese salted fish-a possible etological factor for NPC in china [J]. Int J Cancer, 1994, 59(2): 155-158.
30. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC [J]. Cancer Lett, 1995, 93(1): 17-48.
31. Dodd LE, Sengupta S, Chen IH, et al. Genes involved in DNA repair and nitrosamine metabolism and those located on chromosome 14q32 are dysregulated in nasopharyngeal carcinoma [J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(11): 2216-2225.
32. Chen CJ, Liang KY, Chang YS, et al. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency [J]. Anticancer Res, 1990, 10(2B): 547-553.
33. Zhang F, Zhang J. Clinical hereditary characteristics in nasopharyngeal carcinoma through Ye-Liang's family cluster [J]. Chin Med J (Engl), 1999, 112(2): 185-187.
34. Jia WH, Feng BJ, Xu ZL, et al. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China [J]. Cancer, 2004, 101(2): 363-369.
35. Shanmugaratnam K. Variations in nasopharyngeal cancer incidence among specific Chinese communities (dialect groups) in Singapore [J]. IARC Sci Publ, 1978, 20: 191-198.
36. Meredith RF, Okunewick JP. Genetic influence in murine viral leukemogenesis [J]. Biomedicine, 1976, 24(6): 374-380.
37. Mühlbock O, Dux A. Histocompatibility genes (the H-2 complex) and susceptibility to mammary tumor virus in mice [J]. J Natl Cancer Inst, 1974, 53(4): 993-996.
38. Tennant JR, Snell GD. The H-2 locus and viral leukemogenesis as studied in congenic strains of mice [J]. J Natl Cancer Inst, 1968, 41(2): 597-604.
39. Hirayama T. Descriptive and analytical epidemiology of nasopharyngeal cancer [J]. IARC Sci Publ, 1978, 20: 167-189.
40. Simons MJ, Wee GB, Day NE, et al. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups [J]. Int J Cancer, 1974, 13(1): 122-134.
41. Simons MJ, Day NE, Wee GB, et al. Nasopharyngeal carcinoma V: Immunogenetic studies of Southeast Asian ethnic groups with high and low risk for the tumor [J]. Cancer Res, 1974, 34(5): 1192-1195.
42. Simons MJ, Chan SH, Ho JHC, et al. A Singapore 2-Associated LD Antigen in Chinese Patients with Nasopharyngeal Carcinoma [M]. Kissmeyer-Nielsen F, ed. Histocompatibility Testing 1975: Munksgaard, Copenhagen, 1975: 809-812.
43. Simons MJ, Wee GB, Chan SH, et al. Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma [J]. Lancet, 1975, 1(7899): 142-143.
44. Simons MJ, Day NE. Histocompatibility leukocyte antigen patterns and nasopharyngeal carcinoma [J]. Natl Cancer Inst Monogr, 1977, 47: 143-146.
45. Chan SH, Simons MJ. Immunogenetics of nasopharyngeal carcinoma [J]. Annals Acad Med, 1977, 6(4): 342-346.
46. Simons MJ, Chan SH, Wee GB, et al. Nasopharyngeal carcinoma and histocompatibility antigens [J]. IARC Sci Publ, 1978, 20: 271-282.
47. Feingold N. HLA system and malignant diseases (author's transl) [J]. Bull Cancer, 1978, 65(1): 79-82.
48. Simons MJ, Amiel JL. HLA and Malignant Diseases [M]. Dausset J, Svejgaard A, eds. HLA and Disease: Munksgaard, Copenhagen, 1977: 212-232.
49. Payne R, Radvany R, Grumet C. A new second locus HL-A antigen in linkage disequilibrium with HL-A2 in cantonese chinese [J]. Tissue Antigens, 1975, 5(1): 69-71.
50. Simons MJ, Wheeler R, Cohen D, et al. Restriction fragment length polymorphism of HLA genes. Summary of the Tenth International Workshop Southern blot analysis [M]. Dupont B, ed. Immunobiology of HLA, Vol. 1: Histcompatability testing. New York: Springer-Verlag, 1989: 959-1023.
51. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction [J]. Methods Enzymol, 1987, 155: 335-350.
52. Saiki RK, Bugawan TL, Horn GT, et al. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes [J]. Nature, 1986, 324(6093): 163-166.
53. Chan SH, Day NE, Kunaratnam N, et al. HLA and nasopharyngeal carcinoma in Chinese-a further study [J]. Int J Cancer, 1983, 32: 171-176.
54. Betuel H, Camoun M, Colombani J, et al. The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians [J]. Int J Cancer, 1975, 16(2): 249-254.
55. Trimeche M, Braham H, Ziadi S, et al. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease [J]. Oral Oncol, 2008, 44(8): 775-783.
56. Khabir A, Karray H, Rodriguez S, et al. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas [J]. Virol J, 2005, 2: 39.
57. Frikha M, Toumi N, Ghorbel L, et al. Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities [J]. Cancer Radiother, 2010 Mar 26. [in French]
58. Saemundsen AK, Albeck H, Hansen JP, et al. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes [J]. Br J Cancer, 1982, 46(5): 721-728.
59. Raab-Traub N, Rajadurai P, Flynn K, et al. Epstein-Barr virus infection in carcinoma of the salivary gland [J]. J Virol, 1991, 65(12): 7032-7036.
60. Hamilton-Dutoit SJ, Therkildsen MH, Neilsen NH, et al. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: demonstration of Epstein-Barr virus DNA by in situ nucleic acid hybridization [J]. Hum Pathol, 1991, 22(8): 811-815.
61. Albeck H, Nielsen NH, Hansen HE, et al. Epidemiology of nasopharyngeal and salivary gland carcinoma in Greenland [J]. Arctic Med Res, 1992, 51(4): 189-195.
62. Friborg J, Wohlfahrt J, Koch A, et al. Cancer susceptibility in nasopharyngeal carcinoma families-a population-based cohort study [J]. Cancer Res, 2005, 65(18): 8567-8572.
63. Simons MJ. HLA and Nasopharyngeal Carcinoma: 30 years on [J]. American Society for Histocompatibility and Immunogenetics (ASHI), 2003, 27(2): 52-55.
64. Chan SH, Wee GB. HLA and Nasopharyngeal Cancer in Singapore Chinese [M]. Simons MJ, Tait BD, eds. Proceeding of the Second Asia and Oceania Histocompatibility Workshop Conference: Immunopublishing, Publishing Division of Immunosearch Unit Trust, 445 Toorak Road, Toorak, 3142, Victoria, Australia (ISBN 0 9591744 0 0), 1983: 495-496.
65. Lin M, Chu CC, Chang SL, et al. The origin of Minnan and Hakka, the so-called "Taiwanese", inferred by HLA study [J]. Tissue Antigens, 2001, 57(3): 192-199.
66. Pimtanothai N, Kangwanshiratada O, Charoenwongse P. Serological analysis of human leukocyte antigens-A and-B antigens in Thai patients with nasopharyngeal carcinoma [J]. J Med Assoc Thai, 2003, 86 Suppl 2: S237-S241.
67. Pimtanothai N, Charoenwongse P, Mutirangura A, et al. Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand [J]. Tissue Antigens, 2002, 59(3): 223-225.
68. Hoa BK, Hang NT, Kashiwase K, et al. HLA-A,-B,-C,-DRB1 and-DQB1 alleles and haplotypes in the Kinh population in Vietnam [J]. Tissue Antigens, 2008, 71(2): 127-134.
69. Lin M, Chu CC, Lee HL, et al. Heterogeneity of Taiwan's indigenous population: possible relation to prehistoric Mongoloid dispersals [J]. Tissue Antigens, 2000, 55(1): 1-9.
70. Pool JE, Hellmann I, Jensen JD, et al. Population genetic inference from genomic sequence variation [J]. Genome Res, 2010, 20(3): 291-300.
71. Cavalli-Sforza L. Demic diffusion as the basic process of human expansions [M]. Bellwood P, Renfrew C, eds. Examining the farming / language dispersal hypothesis. McDonald Institute for Archeological Research, Cambridge, UK (ISBN 1-902937-20-1), 2002: 79-88.
72. Oppenheimer S. Following Populations or Molecules? Two contrasting approaches and descriptive outcomes of island colonization arising from a similar knowledge-base [M]. Matsumura S, Forster P, Renfrew C, eds. Simulations, genetics and human prehistory. McDonald Institute for Archeological Research, Cambridge, UK (ISBN 978-1-902937-45-8), 2008: 27-36.
73. Harpending H. Can we read history from haplotypes? [M] Matsumura S, Forster P, Renfrew C, eds. Simulations, genetics and human prehistory. McDonald Institute for Archeological Research, Cambridge, UK (ISBN 978-1-902937-45-8), 2008: 193-197.
74. Ceppellini R, Curtoni ES, Mattiuz PL, et al. Genetics of Leukocyte Antigens: A family study of segregation and linkage [M]. Curtoni ES, Mattiuz PL, Tosi RM, eds. Histocompatibility Testing 1967: The Williams & Wilkins Company, 1967: 149-187.
75. Simons MJ, Inventor; Genetic Technologies Pty. Ltd, Assignee. Genomic mapping method by direct haplotyping using intron sequence analysis [P]. US patent 5851762. Priority date July 11, 1990. Issue date December 22, 1998.
76. www.haplomictechnologies.com.
77. Sanchez-Mazas A. An apportionment of human HLA diversity [J]. Tissue Antigens, 2007, 69 Suppl 1: 198-202.
78. Varney MD, Perko L, Abbott W, et al. Unusual DPA1 and DPB1 heterogeneity contributes to DP polymorphism in Polynesians [M]. Hansen J, ed. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatability Workshop and Conference: International Histocompatibility Working Group Press Fred Hutchinson Cancer Research Center, Seattle, Washington, USA (ISBN 0-945278-03-9), 2006: 157-160.
79. Yu WM, Hussain SS. Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review [J]. J Laryngol Otol, 2009, 123(10): 1067-1074.
80. Hildesheim A, Apple RJ, Chen CJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan [J]. J Natl Cancer Inst, 2002, 94(23): 1780-1789.
81. Yu KJ, Gao X, Chen CJ, et al. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan [J]. Hum Immunol, 2009, 70(11): 910-914.
82. Tang M, Zeng Y, Poisson A, et al. Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population [J]. Genes Immun, 2010, 14: 1-9.
83. Day NE, Simons MJ. Disease susceptibility genes-their identification by multiple case family studies [J]. Tissue Antigens, 1976, 8(2): 109-119.
84. Lu SJ, Day NE, Degos L, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region [J]. Nature, 1990, 346(6283): 470-471.
85. Hu SP, Day NE, Li DR, et al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese [J]. Brit J Cancer, 2005, 92: 967-970.
86. Bertrams J, Sodomann P, Gries FA, et al. HLA association of insulin-dependent diabetes mellitus type I (author's transl) [J]. Dtsch Med Wochenschr, 1981, 106(29-30): 927-932.
87. Tulinius H, Day NE, Bjarnason O, et al. Familial Breast Cancer in Iceland [J]. Int J Cancer, 1982, 29(4): 365-371.
88. Dardari R, Khyatti M, Jouhadi H, et al. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma [J]. Int J Cancer, 2001, 92(2): 294-297.
89. Mokni-Baizig N, Ayed K, Ayed FB, et al. Association between HLA-A/-B antigens and-DRB1 alleles and nasopharyngeal carcinoma in Tunisia [J]. Oncology, 2001, 61(1): 55-58.
90. Ayed K, Bardi R, Gebuhrer L, et al. HLA-A, B, C and DR antigens in a sample of the Tunisian population [J]. Tissue Antigens, 1987, 29(5): 225-231.
91. Makni H, Daoud J, Ben Salah H, et al. HLA association with nasopharyngeal carcinoma in southern Tunisia [J]. Mol Biol Rep, 2009 Aug 28.
92. Li X, Ghandri N, Piancatelli D, et al. Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians [J]. J Transl Med, 2007, 5: 22.
93. Herait P, Tursz T, Guillard MY, et al. HLA-A,-B, and-DR antigens in North African patients with nasopharyngeal carcinoma [J]. Tissue Antigens, 1983, 22(5): 335-341.
94. Dardari R, Khyatti M, Cordeiro P, et al. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients [J]. Int J Cancer, 2006, 118(8): 1977-1983.
95. Li DJ, Bei JX, Mai SJ, et al. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma [J]. J Med Virol, 2009, 81(7): 1253-1260.
96. Chang CM, Yu KJ, Mbulaiteye SM, et al. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal [J]. Virus Res, 2009, 143(2): 209-221.
97. Barber LD, Percival L, Valiante NM, et al. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C [J]. J Exp Med, 1996, 184(2): 735-740.
98. Guo X, Johnson RC, Deng H, et al. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China [J]. Int J Cancer, 2009, 124(12): 2942-2947.
99. Bach FH, Amos DB. Hu-1: Major histocompatibility locus in man [J]. Science, 1967, 156(781): 1506-1508.
100. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J]. Nat Genet, 1996, 13(4), 399-408.
101. Simon M, Bourel M, Fauchet R, et al. Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis [J]. Gut, 1976, 17(5): 332-334.
102. Ajioka RS, Jorde LB, Gruen JR, et al. Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes [J]. Am J Hum Genet, 1997, 60(6), 1439-1447.
103. Lam JC, Roeder K, Devlin B. Haplotype fine mapping by evolutionary trees [J]. Am J Hum Genet, 2000, 66(2): 659-673.
104. Yu HX, Chia JM, Bourque G, et al. A population-based LD map of the human chromosome 6p [J]. Immunogenetics, 2005, 57(8), 559-565.
105. Feng BJ, Huang W, Shugart YY, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4 [J]. Nat Genet, 2002, 31(4): 395-399.
106. Guo XC, Scott K, Liu Y, et al. Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility [J]. Hum Genomics, 2006, 2(6): 365-375.
107. Guo XC, O'Brien SJ, Winkler C, et al. Association study of chromosome 4 STRs polymorphisms with nasopharyngeal carcinoma [J]. Yi Chuan, 2006, 28(7): 783-790.
108. Xiong W, Zeng ZY, Xia JH, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma [J]. Cancer Res, 2004, 64(6): 1972-1974.
109. Zeng Z, Zhou Y, Zhang W, et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus [J]. Genet Med, 2006, 8(3): 156-160.
110. Hu LF, Qiu QH, Fu SM, et al. A genome-wide scan suggests a susceptibility locus on 5p 13 for nasopharyngeal carcinoma [J]. Eur J Hum Genet, 2008, 16(3): 343-349.
111. Ren EC, Law GC, Chan SH. HLA-A2 allelic microvariants in nasopharyngeal carcinoma [J]. Int J Cancer, 1995, 63(2): 213-215.
112. Ooi EE, Ren EC, Chan SH. Association between microsatellites within the human MHC and nasopharyngeal carcinoma [J]. Int J Cancer, 1997, 74(2): 229-232.
113. Lu CC, Chen JC, Jin YT, et al. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese [J]. Int J Cancer, 2003, 103(6): 745-751.
114. Lu CC, Chen JC, Tsai ST, et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping [J]. Int J Cancer, 2005, 115(5): 742-746.
115. Tse KP, Su WH, Chang KP, et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3 [J]. Am J Hum Genet, 2009, 85(2): 194-203.
116. Witt CS, Price P, Kaur G, et al. Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe [J]. Tissue Antigens, 2002, 60(6): 474-480.
117. http://genomics.xprize.org/archon-x-prize-for-genomics/why-whole-genome-sequencing.